These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21881302)

  • 1. [Inhibition mechanism of trypsin by Schiff base metal chelate inhibitors].
    Iyaguchi D
    Yakugaku Zasshi; 2011; 131(9):1299-303. PubMed ID: 21881302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the design of novel Schiff base metal chelate inhibitors of trypsin.
    Iyaguchi D; Kawano S; Takada K; Toyota E
    Bioorg Med Chem; 2010 Mar; 18(6):2076-2080. PubMed ID: 20202854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of guanidine-containing Schiff base copper(II), zinc(II), and iron(III) chelates as trypsin inhibitors.
    Toyota E; Sekizaki H; Itoh K; Tanizawa K
    Chem Pharm Bull (Tokyo); 2003 Jun; 51(6):625-9. PubMed ID: 12808236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray crystallographic analyses of complexes between bovine beta-trypsin and Schiff base copper(II) or iron(III) chelates.
    Toyota E; Ng KK; Sekizaki H; Itoh K; Tanizawa K; James MN
    J Mol Biol; 2001 Jan; 305(3):471-9. PubMed ID: 11152605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Schiff base copper(II) and iron(III) chelates to site-specific cleavage of a trypsin.
    Toyota E; Miyazaki H; Itoh K; Sekizaki H; Tanizawa K
    Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):116-9. PubMed ID: 9987832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schiff base transition metal complexes as novel inhibitors of xanthine oxidase.
    You ZL; Shi DH; Xu C; Zhang Q; Zhu HL
    Eur J Med Chem; 2008 Apr; 43(4):862-71. PubMed ID: 17706325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, structures and urease inhibition studies of Schiff base metal complexes derived from 3,5-dibromosalicylaldehyde.
    Cui Y; Dong X; Li Y; Li Z; Chen W
    Eur J Med Chem; 2012 Dec; 58():323-31. PubMed ID: 23142672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease inhibitors: synthesis and QSAR study of novel classes of nonbasic thrombin inhibitors incorporating sulfonylguanidine and O-methylsulfonylisourea moieties at P1.
    Supuran CT; Scozzafava A; Briganti F; Clare BW
    J Med Chem; 2000 May; 43(9):1793-806. PubMed ID: 10794696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper(II) complexes of coumarin-derived Schiff bases and their anti-Candida activity.
    Creaven BS; Devereux M; Karcz D; Kellett A; McCann M; Noble A; Walsh M
    J Inorg Biochem; 2009 Sep; 103(9):1196-203. PubMed ID: 19631386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypsin inhibitors for the treatment of pancreatitis.
    Brandl T; Simic O; Skaanderup PR; Namoto K; Berst F; Ehrhardt C; Schiering N; Mueller I; Woelcke J
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4340-4. PubMed ID: 27476144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitors: Part 4. Synthesis of weakly basic thrombin inhibitors incorporating pyridinium-sulfanilylaminoguanidine moieties.
    Supuran CT; Briganti F; Scozzafava A; Ilies MA
    J Enzyme Inhib; 2000; 15(4):335-56. PubMed ID: 10995066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some new nano-sized Fe(II), Cd(II) and Zn(II) Schiff base complexes as precursor for metal oxides: Sonochemical synthesis, characterization, DNA interaction, in vitro antimicrobial and anticancer activities.
    Abdel-Rahman LH; Abu-Dief AM; El-Khatib RM; Abdel-Fatah SM
    Bioorg Chem; 2016 Dec; 69():140-152. PubMed ID: 27816797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative structure-activity relationships and molecular graphics in ligand receptor interactions: amidine inhibition of trypsin.
    Recanatini M; Klein T; Yang CZ; McClarin J; Langridge R; Hansch C
    Mol Pharmacol; 1986 Apr; 29(4):436-46. PubMed ID: 3702862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxyethylester-polyrotaxanes as a new calcium chelating polymer: synthesis, calcium binding and mechanism of trypsin inhibition.
    Ooya T; Eguchi M; Ozaki A; Yui N
    Int J Pharm; 2002 Aug; 242(1-2):47-54. PubMed ID: 12176224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and kinetic studies of an amidine-containing phosphonofluoridate: a novel potent inhibitor of trypsin-like enzymes.
    Ni LM; Powers JC
    Bioorg Med Chem; 1998 Oct; 6(10):1767-73. PubMed ID: 9839006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inactivation of serine proteases by nonheme iron complexes.
    Prakash J; Kodanko JJ
    Inorg Chem; 2011 May; 50(9):3934-45. PubMed ID: 21469655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and activity of 2,6-diphenoxypyridine-derived factor Xa inhibitors.
    Phillips G; Davey DD; Eagen KA; Koovakkat SK; Liang A; Ng HP; Pinkerton M; Trinh L; Whitlow M; Beatty AM; Morrissey MM
    J Med Chem; 1999 May; 42(10):1749-56. PubMed ID: 10346927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of benzothiazole guanidines as novel inhibitors of thrombin and trypsin IV.
    Karle M; Knecht W; Xue Y
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4839-43. PubMed ID: 22726924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect.
    Adrover M; Vilanova B; Frau J; Muñoz F; Donoso J
    Bioorg Med Chem; 2008 May; 16(10):5557-69. PubMed ID: 18434162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel beta-lactam derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
    Imbach P; Lang M; García-Echeverría C; Guagnano V; Noorani M; Roesel J; Bitsch F; Rihs G; Furet P
    Bioorg Med Chem Lett; 2007 Jan; 17(2):358-62. PubMed ID: 17095212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.